Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Olga V Anatskaya
 -- 1501 2022-04-08 10:01:09 |
2 format correct
Conner Chen
 -6 word(s) 1495 2022-04-11 05:19:45 |

Video Upload Options

Do you have a full video?
Send video materials Upload full video

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Anatskaya, O. Somatic Polyploidy. Encyclopedia. Available online: https://encyclopedia.pub/entry/21501 (accessed on 03 July 2024).
Anatskaya O. Somatic Polyploidy. Encyclopedia. Available at: https://encyclopedia.pub/entry/21501. Accessed July 03, 2024.
Anatskaya, Olga. "Somatic Polyploidy" Encyclopedia, https://encyclopedia.pub/entry/21501 (accessed July 03, 2024).
Anatskaya, O. (2022, April 08). Somatic Polyploidy. In Encyclopedia. https://encyclopedia.pub/entry/21501
Anatskaya, Olga. "Somatic Polyploidy." Encyclopedia. Web. 08 April, 2022.
Somatic Polyploidy
Edit
This entry is adapted from the peer-reviewed paper 10.3390/ijms23073542

Somatic polyploidy was found in the tissues of all multicellular organisms (including algae, mosses, lichens, vascular plants, invertebrates, and vertebrates), which points to its adaptive value. In human and warm-blooded animals, polyploidy can be a part of normal postnatal morphogenetic programs and can be a manifestation of response to pathological stimuli and diseases.

somatic polyploidy Stress adaptation Functional load Postnatal development

1. Somatic Polyploidy Is a Way of Adaptation to Stress

Somatic polyploidy was found in the tissues of all multicellular organisms (including algae, mosses, lichens, vascular plants, invertebrates, and vertebrates), which points to its adaptive value [1][2]. In human and warm-blooded animals, polyploidy can be a part of normal postnatal morphogenetic programs and can be a manifestation of response to pathological stimuli and diseases. Thus, polyploid cells arise in normal organogenesis of heart, neuronal glia, cerebellum, neocortex, retina, liver, placenta, blood vessels, skin, blood, and other organs [1][3][4][5][6][7] and in atherosclerosis, neurodegenerative disorders, cardiovascular diseases, wound healing, inflammation, diabetes, cancer, and other pathologies [8][9][10][5][7][11][12][13][14][15][16]. Despite the prevalence in normal physiology and pathology, the functional significance of polyploidy still is not clear. Contrary to the old hypothesis, polyploidy is not necessarily required for differentiation and does not have a strong effect on proliferation [17]. Moreover, polyploidy is far from always associated with the increase in protein cell content in proportion to the number of genomes, which makes its role in the regulation of cell and organ size ambiguous [17][18].
Some researchers believe that somatic polyploidy is harmful as it slows down proliferation, inhibits regeneration, reduces cell functionality and promotes genetic instability [19][20][21][22][23][24][25]. Others think that additional genomes are useful as they enhance cell function due to the acceleration of metabolic processes, protein synthesis, regenerative properties, and protect cells from oncogenic transformation [8][1][26][27]. There are also opinions that genomic duplications are neutral as polyploid cells can be an approximate equivalent to the corresponding number of diploid cells [28].
The lack of consensus may originate from the fact that polyploid cells exhibit different properties in tissues with different growth activity and differentiation states. For example, in the growing heart and liver, polyploidization of cardiomyocytes and hepatocytes occur as a result of restriction of the last cell cycle phases (cytokinesis and karyokinesis) and is associated with a slowdown of proliferation [5][29]. In the heart and liver of adult mammals, where the mitotic activity of cardiomyocytes and hepatocytes is extremely low, de novo polyploidization (stimulated by hyperfunction or stress) occurs due to cell cycle reactivation and DNA synthesis [5][13]. In this case, the cells also lose the last phases of the cell cycle, however, the cell cycle activity in these cells is higher than in the resting diploid cells [5].
Despite different manifestations of polyploidy in various biological contexts, there is one important common feature that was previously attributed only to polyploidy in pathology—the association between polyploidy and stress. Extensive analysis of the recent literature indicates that polyploidy is always associated with stress, both in physiologic and pathologic contexts. Thus, in normal mammalian tissues, genome accumulation coincides with critical periods of postnatal growth when cells are forced to combine proliferation and differentiation and to undergo physiological stress [30][9][31][5][32]. Cardiomyocytes accumulate genomes during metabolic maturation coinciding with ROS overproduction and genome instability due to lamina reorganization and transition to the oxygen-rich postnatal environment [33][34]. Macrophage polyploidization during inflammation is also caused by DNA damage [35]. Hepatocytes undergo polyploidization in development in the course of transition from liquid to solid food when the physiological microenvironment is particularly genotoxic [30]. Trophoblast cells duplicate genomes along with decidualization accompanied by the increase in secretory activity and invasiveness [36][37][38].
Stress promotes genome accumulation in quiescent, dormant, and proliferating cells. In quiescent cardiomyocyte and hepatocyte from the adult human and mouse and in the dormant cancer cells that survived treatment, stress induces DNA re-replication resulting in polyploid cell formation [30][13][15][39][40]. In the proliferating cells, physiological stress associated with genome instability can promote polyploidy via the premature cell cycle and disrupted cell differentiation [33]. This phenomenon was described in cardiomyocytes from the hypoplastic left ventricle in the human and neonatal mice [33][41]. It was also observed in cardiomyocytes and hepatocytes of neonatal rats that survived severe inflammatory stress [9][31][11], and in drosophila epithelial cells involved in wound healing [8][42]. Thus, evidence coming from various objects and fields of research suggest that polyploidy is a way of adaptation to stress and related complications like increased ROS production and DNA instability.

2. Polyploid Cells Reduce the Functional Capacity of the Organ

A comparison of polyploidization in hepatocytes and cardiomyocytes of mammals and birds, which differ in functional potential of the heart and liver, indicated how polyploid cells can affect organ function [4][18][43]. For the heart, the functional potential was estimated by the organ mass relative to body mass (heart index), for the liver, by the metabolic scope (i.e., the difference between the basal and maximal metabolic rate). The investigation of 36 species of birds and 30 species of mammals showed that the most severe polyploidization of hepatocytes and cardiomyocytes was observed in the animals with a small metabolic scope and a low heart index, which means that polyploidization reduces the functional potential of the organ [4][18][43].
Paradoxically, organ functional potential in adults inversely correlated with its functional load in neonates. The data obtained with 30 species of wild mammals belonging to six orders indicated that an organ, which works intensively in the adult state, is subjected to a low workload during ontogenesis and plentifully furnished with resources [44]. On the contrary, an organ with low functional potential in the adult state starts to work intensively just after birth and experiences a shortage of resources during growth. This paradox can be explained by the assumption that an organ with high functional potential should be formed under beneficial conditions. Cell ploidy in the adult state positively correlated with the neonatal functional load (as polyploidization is caused by the overlapping of cell function with proliferation during growth). The data obtained with 36 bird species that are either mature or immature at hatching confirmed the positive correlation between adult cardiomyocyte ploidy, maturity and mobility at birth, and cardiac functional load during growth [43][45].
The best examples illustrating these relationships are the couples of sedentary and athletic species with similar weights and differences in the maturity at birth and the organ functional load during neonatal development (when polyploidization begins). Thus, in an excellent athlete wolf (Canis lupus), that is immature-born and has low cardiac functional load during active growth, the average cardiomyocyte ploidy is 4.1 n, and relative heart mass is 0.8%. The corresponding values for a sedentary swine (Sus scrofa) that is mature-born and mobile from birth, are 8.5 n and 0.25% [4][18]. Accordingly, an athletic Cooper’s hawk (that is immature and immobile at hatching, yet able to fly incessantly for 10 h in the adult state) has only 4.1 n per cardiomyocyte and a relative heart mass of about 1.0%, whereas the hen (that is mature and mobile at hatching and can be in the air only for a few seconds in the adult state) has 6.7 n per cardiomyocyte and a relative heart mass about 0.4%. The obtained data contradicted the widespread opinion that polyploidy enhances organ function.

3. Functional Load Can Control Polyploidization during Postnatal Organogenesis of Heart and Liver

In slowly renewing or terminally differentiated organs of warm-blooded animals (e.g., heart and liver), neonatal genome accumulation is irreversible [13][46]. The relationship between polyploidy and the decrease in the organ functional potential makes the factors regulating genome accumulation in somatic cells particularly important. To elucidate this point, the key features of early postnatal development (growth rate, degree of maturity at birth, type of development, metabolic rate) were compared in the large-scale studies of mammals and birds with different polyploidization of cardiomyocytes [4][18][43].
It is well established that neonatal genome accumulation is irreversible as the heart and liver cells are not replaced during the life span [13][46][47]. Recent studies using labeled isotopes (15N and 14C) have confirmed that in humans and mice, cardiomyocytes and hepatocytes can be of the same age as the individual himself [13][46]. The largest number of cells with an extreme life span has been found in the heart, where a complete set of cardiomyocytes is established in postnatal growth and remains stable throughout life [13][46]. Thus, in many mammalian species, cardiomyocytes accumulate genomes during the period of milk feeding (for example, in a rat from seven to fourteen days after birth, in a pig—from a week of age to two months), in birds cardiomyocyte genome accumulation proceeds during the interval from birth to maturation [4][18][43]. In humans, polyploidization occurred mostly from birth to 11 years [13][48]. Consequently, factors regulating this process in adult animals should be sought in early postnatal development (in childhood). The studies of cardiomyocyte ploidy in more than 80 species of birds and mammals indicated that the degree of polyploidization reflects cardiac functional load during growth [18][43][45][49]. Cardiomyocytes of precocious mammals and birds, which are relatively mature and mobile from hatching or birth, contain 1.6 fold more genomes than cardiomyocytes of altricious species of similar weight, which are helpless at hatching or birth and show weak mobility during growth [18][43]. Thus, cardiac functional load during critical developmental windows is important for polyploidization.

References

  1. Fox, D.T.; Soltis, D.E.; Soltis, P.S.; Ashman, T.-L.; Van de Peer, Y. Polyploidy: A Biological Force From Cells to Ecosystems. Trends Cell Biol. 2020, 30, 688–694.
  2. Van de Peer, Y.; Mizrachi, E.; Marchal, K. The Evolutionary Significance of Polyploidy. Nat. Rev. Genet. 2017, 18, 411–424.
  3. Otto, S.P. The Evolutionary Consequences of Polyploidy. Cell 2007, 131, 452–462.
  4. Anatskaya, O.V.; Vinogradov, A.E. Heart and Liver as Developmental Bottlenecks of Mammal Design: Evidence from Cell Polyploidization. Biol. J. Linn. Soc. 2004, 83, 175–186.
  5. Lazzeri, E.; Angelotti, M.L.; Conte, C.; Anders, H.-J.; Romagnani, P. Surviving Acute Organ Failure: Cell Polyploidization and Progenitor Proliferation. Trends Mol. Med. 2019, 25, 366–381.
  6. Nandakumar, S.; Rozich, E.; Buttitta, L. Cell Cycle Re-Entry in the Nervous System: From Polyploidy to Neurodegeneration. Front. Cell Dev. Biol. 2021, 9, 698661.
  7. Bailey, E.C.; Kobielski, S.; Park, J.; Losick, V.P. Polyploidy in Tissue Repair and Regeneration. Cold Spring Harb. Perspect. Biol. 2021, 13, a040881.
  8. Gjelsvik, K.J.; Besen-McNally, R.; Losick, V.P. Solving the Polyploid Mystery in Health and Disease. Trends Genet. 2019, 35, 6–14.
  9. Anatskaya, O.V.; Vinogradov, A.E. Genome Multiplication as Adaptation to Tissue Survival: Evidence from Gene Expression in Mammalian Heart and Liver. Genomics 2007, 89, 70–80.
  10. Anatskaya, O.V.; Vinogradov, A.E. Somatic Polyploidy Promotes Cell Function under Stress and Energy Depletion: Evidence from Tissue-Specific Mammal Transcriptome. Funct. Integr. Genom. 2010, 10, 433–446.
  11. Anatskaya, O.V.; Matveev, I.V.; Sidorenko, N.V.; Kharchenko, M.V.; Kropotov, A.V.; Vinogradov, A.E. Changes in the Heart of Neonatal Rats after Cryptosporidial Gastroenteritis of Different Degrees of Severity. J. Evol. Biochem. Physiol. 2013, 49, 509–518.
  12. Silva, I.S.; Ghiraldini, F.G.; Veronezi, G.M.B.; Mello, M.L.S. Polyploidy and Nuclear Phenotype Characteristics of Cardiomyocytes from Diabetic Adult and Normoglycemic Aged Mice. Acta Histochem. 2018, 120, 84–94.
  13. Derks, W.; Bergmann, O. Polyploidy in Cardiomyocytes: Roadblock to Heart Regeneration? Circ. Res. 2020, 126, 552–565.
  14. Erenpreisa, J.; Salmina, K.; Anatskaya, O.; Cragg, M.S. Paradoxes of Cancer: Survival at the Brink. In Seminars in Cancer Biology; Academic Press: Cambridge, MA, USA, 2020.
  15. Kirillova, A.; Han, L.; Liu, H.; Kühn, B. Polyploid Cardiomyocytes: Implications for Heart Regeneration. Dev. Camb. Engl. 2021, 148, dev199401.
  16. Neiman, M.; Beaton, M.J.; Hessen, D.O.; Jeyasingh, P.D.; Weider, L.J. Endopolyploidy as a Potential Driver of Animal Ecology and Evolution. Biol. Rev. Camb. Philos. Soc. 2017, 92, 234–247.
  17. Pandit, S.K.; Westendorp, B.; de Bruin, A. Physiological Significance of Polyploidization in Mammalian Cells. Trends Cell Biol. 2013, 23, 556–566.
  18. Anatskaya, O.V.; Vinogradov, A.E. Paradoxical Relationship between Protein Content and Nucleolar Activity in Mammalian Cardiomyocytes. Genome 2004, 47, 565–578.
  19. Quinton, R.J.; DiDomizio, A.; Vittoria, M.A.; Kotýnková, K.; Ticas, C.J.; Patel, S.; Koga, Y.; Vakhshoorzadeh, J.; Hermance, N.; Kuroda, T.S.; et al. Whole-Genome Doubling Confers Unique Genetic Vulnerabilities on Tumour Cells. Nature 2021, 590, 492–497.
  20. Lin, H.; Huang, Y.-S.; Fustin, J.-M.; Doi, M.; Chen, H.; Lai, H.-H.; Lin, S.-H.; Lee, Y.-L.; King, P.-C.; Hou, H.-S.; et al. Hyperpolyploidization of Hepatocyte Initiates Preneoplastic Lesion Formation in the Liver. Nat. Commun. 2021, 12, 645.
  21. Zheng, L.; Dai, H.; Zhou, M.; Li, X.; Liu, C.; Guo, Z.; Wu, X.; Wu, J.; Wang, C.; Zhong, J.; et al. Polyploid Cells Rewire DNA Damage Response Networks to Overcome Replication Stress-Induced Barriers for Tumour Progression. Nat. Commun. 2012, 3, 815.
  22. Patterson, M.; Swift, S.K. Residual Diploidy in Polyploid Tissues: A Cellular State with Enhanced Proliferative Capacity for Tissue Regeneration? Stem Cells Dev. 2019, 28, 1527–1539.
  23. Müller, M.; May, S.; Bird, T.G. Ploidy Dynamics Increase the Risk of Liver Cancer Initiation. Nat. Commun. 2021, 12, 1896.
  24. Clay, D.E.; Fox, D.T. DNA Damage Responses during the Cell Cycle: Insights from Model Organisms and Beyond. Genes 2021, 12, 1882.
  25. Matsumoto, T.; Wakefield, L.; Peters, A.; Peto, M.; Spellman, P.; Grompe, M. Proliferative Polyploid Cells Give Rise to Tumors via Ploidy Reduction. Nat. Commun. 2021, 12, 646.
  26. Zhang, S.; Zhou, K.; Luo, X.; Li, L.; Tu, H.-C.; Sehgal, A.; Nguyen, L.H.; Zhang, Y.; Gopal, P.; Tarlow, B.D.; et al. The Polyploid State Plays a Tumor-Suppressive Role in the Liver. Dev. Cell 2018, 44, 447–459.e5.
  27. Newcomb, R.; Dean, E.; McKinney, B.J.; Alvarez, J.V. Context-Dependent Effects of Whole-Genome Duplication during Mammary Tumor Recurrence. Sci. Rep. 2021, 11, 14932.
  28. Windner, S.E.; Manhart, A.; Brown, A.; Mogilner, A.; Baylies, M.K. Nuclear Scaling Is Coordinated among Individual Nuclei in Multinucleated Muscle Fibers. Dev. Cell 2019, 49, 48–62.e3.
  29. Patterson, M.; Barske, L.; Van Handel, B.; Rau, C.D.; Gan, P.; Sharma, A.; Parikh, S.; Denholtz, M.; Huang, Y.; Yamaguchi, Y.; et al. Frequency of Mononuclear Diploid Cardiomyocytes Underlies Natural Variation in Heart Regeneration. Nat. Genet. 2017, 49, 1346–1353.
  30. Donne, R.; Saroul-Aïnama, M.; Cordier, P.; Celton-Morizur, S.; Desdouets, C. Polyploidy in Liver Development, Homeostasis and Disease. Nat. Rev. Gastroenterol. Hepatol. 2020, 17, 391–405.
  31. Anatskaya, O.V.; Sidorenko, N.V.; Beyer, T.V.; Vinogradov, A.E. Neonatal Cardiomyocyte Ploidy Reveals Critical Windows of Heart Development. Int. J. Cardiol. 2010, 141, 81–91.
  32. Porrello, E.R.; Olson, E.N. A Neonatal Blueprint for Cardiac Regeneration. Stem Cell Res. 2014, 13, 556–570.
  33. Puente, B.N.; Kimura, W.; Muralidhar, S.A.; Moon, J.; Amatruda, J.F.; Phelps, K.L.; Grinsfelder, D.; Rothermel, B.A.; Chen, R.; Garcia, J.A.; et al. The Oxygen-Rich Postnatal Environment Induces Cardiomyocyte Cell-Cycle Arrest through DNA Damage Response. Cell 2014, 157, 565–579.
  34. Han, L.; Choudhury, S.; Mich-Basso, J.D.; Ammanamanchi, N.; Ganapathy, B.; Suresh, S.; Khaladkar, M.; Singh, J.; Maehr, R.; Zuppo, D.A.; et al. Lamin B2 Levels Regulate Polyploidization of Cardiomyocyte Nuclei and Myocardial Regeneration. Dev. Cell 2020, 53, 42–59.e11.
  35. Herrtwich, L.; Nanda, I.; Evangelou, K.; Nikolova, T.; Horn, V.; Erny, D.; Stefanowski, J.; Rogell, L.; Klein, C.; Gharun, K.; et al. DNA Damage Signaling Instructs Polyploid Macrophage Fate in Granulomas. Cell 2016, 167, 1264–1280.e18.
  36. Zybina, T.G.; Stein, G.I.; Pozharisski, K.M.; Zybina, E.V. Invasion and Genome Reproduction of the Trophoblast Cells of Placenta Junctional Zone in the Field Vole, Microtus Rossiaemeridionalis. Cell Biol. Int. 2014, 38, 136–143.
  37. Zybina, T.G.; Zybina, E.V. Role of Cell Cycling and Polyploidy in Placental Trophoblast of Different Mammalian Species. Reprod. Domest. Anim. Zuchthyg. 2020, 55, 895–904.
  38. Zybina, T.G. Genome Modifications Involved in Developmental Programs of the Placental Trophoblast. In Cytogenetics-Classical and Molecular Strategies for Analysing Heredity Material; Larramendy, M., Soloneski, S., Eds.; IntechOpen: London, UK, 2021; ISBN 978-1-83968-941-3.
  39. Brodsky, V.Y.; Sarkisov, D.S.; Arefyeva, A.M.; Panova, N.W.; Gvasava, I.G. Polyploidy in Cardiac Myocytes of Normal and Hypertrophic Human Hearts; Range of Values. Virchows Arch. Int. J. Pathol. 1994, 424, 429–435.
  40. Herget, G.W.; Neuburger, M.; Plagwitz, R.; Adler, C.P. DNA Content, Ploidy Level and Number of Nuclei in the Human Heart after Myocardial Infarction. Cardiovasc. Res. 1997, 36, 45–51.
  41. Krane, M.; Dreßen, M.; Santamaria, G.; My, I.; Schneider, C.M.; Dorn, T.; Laue, S.; Mastantuono, E.; Berutti, R.; Rawat, H.; et al. Sequential Defects in Cardiac Lineage Commitment and Maturation Cause Hypoplastic Left Heart Syndrome. Circulation 2021, 144, 1409–1428.
  42. Besen-McNally, R.; Gjelsvik, K.J.; Losick, V.P. Wound-Induced Polyploidization Is Dependent on Integrin-Yki Signaling. Biol. Open 2021, 10, bio055996.
  43. Anatskaya, O.V.; Vinogradov, A.E. Myocyte Ploidy in Heart Chambers of Birds with Different Locomotor Activity. J. Exp. Zool. 2002, 293, 427–441.
  44. Liberzon, A.; Birger, C.; Thorvaldsdóttir, H.; Ghandi, M.; Mesirov, J.P.; Tamayo, P. The Molecular Signatures Database (MSigDB) Hallmark Gene Set Collection. Cell Syst. 2015, 1, 417–425.
  45. Anatskaya, O.V.; Vinogradov, A.E.; Kudryavtsev, B.N. Cardiomyocyte Ploidy Levels in Birds with Different Growth Rates. J. Exp. Zool. 2001, 289, 48–58.
  46. Drigo, A.E.R.; Lev-Ram, V.; Tyagi, S.; Ramachandra, R.; Deerinck, T.; Bushong, E.; Phan, S.; Orphan, V.; Lechene, C.; Ellisman, M.H.; et al. Age Mosaicism across Multiple Scales in Adult Tissues. Cell Metab. 2019, 30, 343–351.e3.
  47. Brodsky, W.Y.; Uryvaeva, I.V. Cell Polyploidy: Its Relation to Tissue Growth and Function. Int. Rev. Cytol. 1977, 50, 275–332.
  48. Mollova, M.; Bersell, K.; Walsh, S.; Savla, J.; Das, L.T.; Park, S.-Y.; Silberstein, L.E.; Dos Remedios, C.G.; Graham, D.; Colan, S.; et al. Cardiomyocyte Proliferation Contributes to Heart Growth in Young Humans. Proc. Natl. Acad. Sci. USA 2013, 110, 1446–1451.
  49. Vinogradov, A.E.; Anatskaya, O.V.; Kudryavtsev, B.N. Relationship of Hepatocyte Ploidy Levels with Body Size and Growth Rate in Mammals. Genome 2001, 44, 350–360.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Cell Biology
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Olga Anatskaya
View Times: 554
Revisions: 2 times (View History)
Update Date: 11 Apr 2022
Table of Contents
    1000/1000
    Hot Most Recent
    Video Production Service
    Feedback